Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Capsule Content Uniformity

Posted on By

SOP for Capsule Content Uniformity

Procedure for Capsule Content Uniformity Testing

1) Purpose

The purpose of this SOP is to outline the procedure for testing the content uniformity of capsules to ensure consistent distribution of active pharmaceutical ingredient (API) across all dosage units.

2) Scope

This SOP applies to all capsule batches produced within the manufacturing facility.

3) Responsibilities

Quality Control (QC) Department: Responsible for conducting content uniformity testing and ensuring compliance with this SOP.
Production Department: Responsible for providing capsule samples for testing and maintaining process parameters.

4) Procedure

4.1 Sampling:
    4.1.1 Select a statistically valid number of capsules from the batch according to the sampling plan (e.g., 30 capsules).
    4.1.2 Ensure the capsules are randomly chosen to represent the entire batch.

See also  SOP for Determination of Moisture Content

4.2 Equipment Preparation:
    4.2.1 Set up the equipment for content uniformity testing (e.g., HPLC system) as per the manufacturer’s instructions.
    4.2.2 Ensure the equipment is calibrated and validated for the analysis.

4.3 Content Uniformity Testing Procedure:
    4.3.1 Remove the contents of each selected capsule and weigh the total amount of API.
    4.3.2 Prepare a composite sample by combining the contents of all selected capsules.
    4.3.3 Analyze the composite sample using an appropriate analytical method (e.g., HPLC) to determine the API content.
    4.3.4 Calculate the mean and relative standard

deviation (RSD) of API content to assess uniformity.

4.4 Acceptance Criteria:
    4.4.1 The capsule batch is acceptable if the RSD of API content does not exceed the specified limit (e.g., 6.0%).

See also  SOP for Syringe Plunger Force Testing

4.5 Documentation:
    4.5.1 Document all results, calculations, chromatograms, and sample preparation details in the Capsule Content Uniformity Test Record.
    4.5.2 Review and approve the documentation by QC Manager.

5) Abbreviations, if any

QC: Quality Control
API: Active Pharmaceutical Ingredient
HPLC: High-Performance Liquid Chromatography
RSD: Relative Standard Deviation

6) Documents, if any

Capsule Content Uniformity Test Record
Calibration Record for Analytical Equipment
Sampling Plan Document

7) Reference, if any

USP <905> – Uniformity of Dosage Units (Capsules)
21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals

8) SOP Version

Version 1.0

In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Environmental Monitoring: Regular Monitoring of Environmental Conditions (Temperature, Humidity, Cleanliness) in the Manufacturing Area to Maintain Product Quality
Next Post: SOP for Packaging Inspection: Ensuring That Packaging Materials Are Free from Defects and That the Final Packaged Product Meets Quality Standards

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version